The pattern of KRAS mutations in non-small cell lung cancer (NSCLC): A retrospective study from south-eastern Georgia.

被引:0
|
作者
Matosz, Sabrina
Elzaidy, Mostafa
Karim, Nagla Fawzy Abdel
机构
[1] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[2] Maadi Mil Hosp, Cairo, Egypt
[3] Augusta Univ, Med Ctr, Augusta, GA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
15110
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] ANALYSIS OF KRAS MUTATIONS IN NON-SMALL CELL LUNG CANCER (NSCLC) BRAZILIAN PATIENTS
    Couto, Patricia G. P.
    Bastos-rodrigues, Luciana
    Sabato, Cristina
    Guieiro, Fernanda
    Vilhena, Alyne
    Amaral, Nilson F.
    De Marco, Luiz
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S735 - S736
  • [3] Prognostic significance and origin of plasma KRAS mutations in patients with non-small cell lung cancer (NSCLC)
    Gautschi, Oliver
    Ziegler, Annemarie
    Huegli, Barbara
    Gugger, Mathias
    Ratschiller, Daniel
    Mack, Philip C.
    Kung, Hsing-Jien
    Stahel, Rolf A.
    Gandara, David R.
    Betticher, Daniel C.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S443 - S443
  • [4] Exploring the association between KRAS mutations and depression in non-small cell lung cancer (NSCLC) patients
    Li, Jenny Jing
    Harper, Jessica
    Bhulani, Nizar
    Gerber, David E.
    Khan, Saad A.
    Madrigales, Alejandra
    Gates, Samantha
    Toups, Marisa
    Beg, Muhammad Shaalan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31)
  • [5] KRAS mutations in the circulating free DNA (cfDNA) of non-small cell lung cancer (NSCLC) patients
    Garzon, Monica
    Villatoro, Sergi
    Teixido, Cristina
    Mayo, Clara
    Martinez, Alejandro
    Llanos Gil, Maria de Los
    Viteri, Santiago
    Morales-Espinosa, Daniela
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (05) : 511 - 516
  • [6] The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study
    Boch, Christian
    Kollmeier, Jens
    Roth, Andreas
    Stephan-Falkenau, Susann
    Misch, Daniel
    Gruening, Wolfram
    Bauer, Torsten Thomas
    Mairinger, Thomas
    BMJ OPEN, 2013, 3 (04):
  • [7] KRAS in non-small cell lung cancer
    Amanam, I.
    Gupta, R.
    Mambetsariev, I.
    Koczywas, M.
    Cristea, M.
    Massarelli, E.
    Reckamp, K. L.
    Salgia, R.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations: A retrospective multicenter study.
    Ji, Jingran
    Aredo, Jacqueline, V
    Piper-Vallillo, Andrew
    Huppert, Laura
    Rotow, Julia K.
    Husain, Hatim
    Stewart, Susan L.
    Cobb, Rosemary
    Wakelee, Heather A.
    Blakely, Collin Michael
    Wong, Melisa L.
    Gubens, Matthew A.
    Chen, Justin
    Oxnard, Geoffrey R.
    McCoach, Caroline Elizabeth
    Piotrowska, Zofia
    Neal, Joel W.
    Riess, Jonathan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study
    Bircan, Sema
    Baloglu, Huseyin
    Kucukodaci, Zafer
    Bircan, Ahmet
    MEDICAL ONCOLOGY, 2014, 31 (08)
  • [10] A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations
    Lei, Lei
    Wang, Wen-xian
    Yu, Zong-yang
    Liang, Xian-bin
    Pan, Wei-wei
    Chen, Hua-fei
    Wang, Li-ping
    Fang, Yong
    Wang, Min
    Xu, Chun-wei
    Fang, Mei-yu
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 329 - 335